Search

You searched for "procedures"

5478 results found

Management of giant retinal tears with vitrectomy and perfluorocarbon liquid postoperatively as a short-term tamponade

1 April 2018 | | EYE - Vitreo-Retinal
The authors report an eight year retrospective case series study of 30 eyes of 29 patients with who underwent a giant retinal tear-related retinal detachment repair. M: F ratio was 23:6. Right to left eye ratio was 16:14. The mean...

Comparison of retinal pigment epithelium-choroid graft surgery and anti-VEGF therapy in patients with wet AMD

1 December 2015 | | EYE - Vitreo-Retinal
This was a randomised intervention study in wet AMD patients to investigate benefits of free RPE-choroid graft transplantation surgery versus (continuation of) anti-VEGF treatment. Twenty patients who met the inclusion criteria were subdivided into three subgroups, i.e. RPE tears involving...

Stereotactic radiotherapy for polypoidal choroidal vasculopathy

1 August 2015 | | EYE - Vitreo-Retinal
Polypoidal choroidal vasculopathy (PCV) is a variant of neovascular AMD. It is a disease of choroidal vasculature characterised by abnormal branching vascular network with aneurysmal dilatations (polyps). Features of PCV include pigment epithelial detachments (PED), subretinal fluid (SRF) accumulation and...

Does paediatric uveitis reactivate after treatment with anti-TNF-a drugs?

1 June 2015 | | EYE - Vitreo-Retinal
As a potentially blinding disease that can affect 7-27/100000 children, uveitis remains a rare condition, where little evidence based data is available to guide management decisions. Most paediatric uveitis cases are chronic, anterior and non-infectious and may be associated with...

RaScaL Study

1 June 2015 | | EYE - Vitreo-Retinal
The RaScaL study was a six month, single-centre, controlled, prospective phase I/II study in which subjects with diabetic macular oedema (DME) and associated peripheral nonperfusion on ultrawide-field fluorescein angiography (UWFA) were randomised to: (1) study arm: ranibizumab (0.5 mg) injection...

Orbital cellulitis in Scotland: current incidents, aetiology, management and outcomes

1 February 2015 | | EYE - Oculoplastic, EYE - Orbit
This is a one year prospective study using the Scottish ophthalmic surveillance unit reporting system amongst Scottish ophthalmologists. Only patients residing within Scotland with a new diagnosis of orbital cellulitis between November 2011 and October 2012 were including in this...

Incidence and risk factors of ocular hypertension following PPV and SOI

1 December 2018 | | EYE - Vitreo-Retinal
In this prospective, interventional study the authors evaluated the risk factors for elevated intraocular pressure (IOP) after pars plana vitrectomy (PPV) with silicone oil injection (SOI). This study included 254 eyes of 254 patients, with a mean age of 55.33...

Patients with low vision benefit from optical sector seeing ‘beyond the eyes’

26 February 2019
Patients with low vision are benefitting from an initiative developed by Visualise Training and Consultancy and funded by Thomas Pocklington Trust. Seeing Beyond the Eyes has released its impact report which highlights a huge increase in the number of optical professionals who will now refer patients with low vision to vital support services – up from only 9% to an impressive 96%.

Ophthalmic history made easy

13 March 2019
There are now three ophthalmic medical documentaries to dip into on to Royal College of Ophthalmologists website.

Deadline approaching for Edinburgh scholarship applications

19 June 2019
The University of Edinburgh has opened applications for scholarships to its two online courses, the MSc in Primary Care Ophthalmology and the ChM in Clinical Ophthalmology.

Viral conjunctivitis and COVID-19

23 March 2020
A joint statement was released by the Royal College of Ophthalmologists and College of Optometrists on 19 March.

Johnson & Johnson announces lead vaccine candidate for COVID-19

30 March 2020
Johnson & Johnson has announced the selection of a lead COVID-19 vaccine candidate and the rapid scaling of its manufacturing capacity with the goal of providing global supply of more than one billion doses.